Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.

Study shows high-dose vaccines work better for older adults while cell-based versions benefit younger people as respiratory ...

Artificial intelligence (AI) and “protein language” models can speed the design of monoclonal antibodies that prevent or ...

Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to ...

ALTHOUGH THE IMMUNE system appreciates rest and sleep, it also recharges thanks to regular exercise. Even just taking a five- ...

Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or ...

The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...

Hitting your 50s or 60s won’t dim that spark—you’ve still got. But that doesn’t mean it’s effortless. Your immune system ...

Multiple studies have shown that Covid infection increases the risk of cardiovascular diseases, including heart attack and ...

Mucosal delivery through inhalation, nasal sprays or topical application allows antibodies to target infection sites directly ...

For decades, scientists believed molecules called leukotrienes were the main culprits behind asthma’s airway-constricting ...

Queensland University of Technology; Joy Lee, Monash University      Queensland, Nov 11 (The Conversation) You’ve been through winter lurgies and ...